Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to $123.1 million.

  • Usana Health Sciences' Total Non-Current Liabilities rose 303.33% to $123.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.1 million, marking a year-over-year increase of 303.33%. This contributed to the annual value of $143.7 million for FY2024, which is 1645.18% up from last year.
  • Per Usana Health Sciences' latest filing, its Total Non-Current Liabilities stood at $123.1 million for Q3 2025, which was up 303.33% from $126.3 million recorded in Q2 2025.
  • Usana Health Sciences' Total Non-Current Liabilities' 5-year high stood at $180.1 million during Q1 2021, with a 5-year trough of $108.5 million in Q2 2024.
  • For the 5-year period, Usana Health Sciences' Total Non-Current Liabilities averaged around $140.0 million, with its median value being $137.3 million (2022).
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 2302.36% in 2021, then plummeted by 2120.4% in 2022.
  • Usana Health Sciences' Total Non-Current Liabilities (Quarter) stood at $165.8 million in 2021, then decreased by 10.8% to $147.9 million in 2022, then fell by 16.57% to $123.4 million in 2023, then increased by 16.45% to $143.7 million in 2024, then fell by 14.31% to $123.1 million in 2025.
  • Its Total Non-Current Liabilities was $123.1 million in Q3 2025, compared to $126.3 million in Q2 2025 and $142.2 million in Q1 2025.